Scientech Research’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$356K Buy
+50,593
New +$377K 1.53% 27
2025
Q4
– Sell
-7,180
Closed -$290K – 665
2025
Q3
$290K Buy
+7,180
New +$416K 0.1% 387
2024
Q3
– Sell
-1,819
Closed -$133K – 734
2024
Q2
$133K Sell
1,819
-4,342
-70% -$366K 0.03% 542
2024
Q1
$449K Buy
+6,161
New +$514K 0.24% 187

Other funds holding LABD

Scientech Research's LABD Position: Q3 2026 in Review

Scientech Research opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2026: 50,593 shares worth $356K. The stake represents 1.53% of the portfolio and ranks #27 among its holdings. This is a return to the name: Scientech Research previously reported a position in LABD as recently as Q3 2025.

Scientech Research first reported a position in LABD in Q1 2024 and has held it in 4 quarters since. The position peaked at $449K in Q1 2024. 20 funds tracked by Wall St. Rank hold LABD as of Q3 2026.

  • Scientech Research held 50,593 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $356K as of Q3 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF was a new Scientech Research position in Q3 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up 1.53% of Scientech Research's portfolio in Q3 2026, its #27 holding.
  • Scientech Research first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2024 and has held it in 4 quarters since.
  • Scientech Research's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $449K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2026.

Based on Scientech Research's 13F filing for Q3 2026, filed 16 Nov 2026.